TP53 and central nervous system cancer: To comprehensively interrogate inter-tumoral heterogeneity in stem cell populations from IDH1- and TP53-mutant gliomas, we profiled snap-frozen tumor samples from 6 patients (Fig. 1C; Table 1) using full-length single nucleus RNA sequencing (snRNA-seq).